DPH Dechra Pharmaceuticals Plc

TIDMDPH

RNS Number : 9729K

Dechra Pharmaceuticals PLC

07 September 2021

7 September 2021

LEI: 213800J4UVB5OWG8VX82

Dechra(R) Pharmaceuticals PLC

(Dechra or the Company)

Availability of 2021 Annual Report and Accounts

The 2021 Annual Report and Accounts is now available to view at www.dechra.com.

The following documents are scheduled to be mailed to registered shareholders of the Company on 20 September 2021:

   --      2021 Annual Report and Accounts 
   --      Notice of the 2021 Annual General Meeting; and 
   --      Proxy Form for the 2021 Annual General Meeting. 

In accordance with Listing Rule 9.6.1 a copy of each of these documents will be submitted to the National Storage Mechanism and will be available for viewing shortly after posting.

For further information, please contact:

Melanie Hall, Company Secretary

Telephone number: +44 (0) 1606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACSEAPNXEAEFEEA

(END) Dow Jones Newswires

September 07, 2021 04:34 ET (08:34 GMT)

Grafico Azioni Dechra Pharmaceuticals (LSE:DPH)
Storico
Da Mar 2024 a Apr 2024

Grafico Azioni Dechra Pharmaceuticals (LSE:DPH)
Storico
Da Apr 2023 a Apr 2024